1. Home
  2. MURA vs SNT Comparison

MURA vs SNT Comparison

Compare MURA & SNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • SNT
  • Stock Information
  • Founded
  • MURA 2013
  • SNT 1965
  • Country
  • MURA Ireland
  • SNT Canada
  • Employees
  • MURA N/A
  • SNT N/A
  • Industry
  • MURA
  • SNT Telecommunications Equipment
  • Sector
  • MURA
  • SNT Telecommunications
  • Exchange
  • MURA Nasdaq
  • SNT Nasdaq
  • Market Cap
  • MURA 57.2M
  • SNT 64.6M
  • IPO Year
  • MURA N/A
  • SNT 1993
  • Fundamental
  • Price
  • MURA $4.00
  • SNT $3.36
  • Analyst Decision
  • MURA Strong Buy
  • SNT
  • Analyst Count
  • MURA 4
  • SNT 0
  • Target Price
  • MURA $16.00
  • SNT N/A
  • AVG Volume (30 Days)
  • MURA 239.2K
  • SNT 46.0K
  • Earning Date
  • MURA 11-13-2024
  • SNT 11-12-2024
  • Dividend Yield
  • MURA N/A
  • SNT N/A
  • EPS Growth
  • MURA N/A
  • SNT N/A
  • EPS
  • MURA N/A
  • SNT 0.06
  • Revenue
  • MURA N/A
  • SNT $34,455,000.00
  • Revenue This Year
  • MURA N/A
  • SNT N/A
  • Revenue Next Year
  • MURA N/A
  • SNT N/A
  • P/E Ratio
  • MURA N/A
  • SNT $57.79
  • Revenue Growth
  • MURA N/A
  • SNT 2.04
  • 52 Week Low
  • MURA $2.87
  • SNT $1.08
  • 52 Week High
  • MURA $5.62
  • SNT $3.75
  • Technical
  • Relative Strength Index (RSI)
  • MURA 66.06
  • SNT 53.04
  • Support Level
  • MURA $3.55
  • SNT $3.06
  • Resistance Level
  • MURA $4.05
  • SNT $3.75
  • Average True Range (ATR)
  • MURA 0.24
  • SNT 0.22
  • MACD
  • MURA 0.07
  • SNT -0.06
  • Stochastic Oscillator
  • MURA 91.35
  • SNT 43.48

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.

Share on Social Networks: